T Cell Receptor-Mediated Signaling Is Defective in T Cells Obtained from Patients with Primary Intracranial Tumors

Journal of Immunology

Volumn 159, Issue 9, 1997, Pages 4415-4425

  Morford, Lorri A ^a   Elliott, Lucinda H ^a   Carlson, Sonia L ^a   Brooks, William H ^a   Roszman, Thomas L ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHOLIPASE C;

ARTICLE; BRAIN TUMOR; GLIOMA; HUMAN; IMMUNOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GLIOMA; HUMANS; PHOSPHOLIPASE C; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031278368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Brooks, W. H., M. G. Netsky, D. E. Normansell, and D. A. Horwitz. 1972. Depressed cell-mediated immunity in patients with primary intracranial tumors. J. Exp. Med. 136:1631.
2. Young, H. F., R. Sakalas, and A. M. Kaplan. 1976. Inhibition of cell mediated immunity in patients with brain tumors. Surg. Neurol. 5:19.
3. Brooks, W. H., T. L. Roszman, and A. S. Rogers. 1976. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. Cancer 37: 1869.
4. Mahaley, M. S., W. H. Brooks, T. L. Roszman, D. D. Bigner, L. Suka, and S. Richardson. 1977. Immunobiology of primary intracranial tumors. Part 1. Studies of the cellular and humoral general immune competence of brain-tumor patients. J. Neurosurg. 46:467.
5. Brooks, W. H., T. L. Roszman, M. S. Mahaley, and R. Woosley. 1977. Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clin. Exp. Immunol. 29:61.
6. Levy, N. L. 1978. Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their association determinants on human tumor cells are different. J. Imunol. 121:916.
7. Roszman, T. L., and W. H. Brooks. 1980. Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin. Exp. Immunol. 39:395.
8. Braun, D. P., R. D. Penn, A. M. Flannery, and J. H. Harris. 1982. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10:203.
9. Roszman, T. L., W. H. Brooks, C. Steele, and L. H. Elliott. 1985. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors: characterization of T helper and B cell function. J. Immunol. 134:1545.
10. Elliott, L. H., W. H. Brooks, and T. L. Roszman. 1987. Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas. J. Neurosurg. 67:231.
11. Elliott, L. H., W. H. Brooks, and T. L. Roszman. 1984. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J. Immunol. 132:1208.
12. Elliott, L., W. Brooks, and T. Roszman. 1987. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. J. Natl. Cancer Inst. 78:919.
13. Elliott, L. H., W. H. Brooks, and T. L. Roszman. 1990. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors. J. Clin. Invest. 86:80.
14. Chan, A. C., D. M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555.
15. Isakov, N., M. I. Mally, W. Scholz, and A. Altman. 1987. T-lymphocyte activation: the role of protein kinase C and the bifurcating inositiol phospholipid signal transduction pathway. Immunol. Rev. 95:89.
16. Hsi, E. D., J. N. Siegel, Y. Minami, E. T. Luong, R. D. Klausner, and L. E. Samelson. 1989. T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J. Biol Chem. 264:10836.
17. Patel, M., L. E. Samelson, and R. D. Klausner. 1987. Multiple kinases and signal transduction: phosphorylation of the T cell antigen receptor complex. J. Biol. Chem. 262:5831.
18. Weissman, A. M., P. Ross, E. T. Luong, P. Garcia-Morales, M. L. Jelachich, W. E. Biddison, R. D. Klausner, and L. E. Samelson. 1988. Tyrosine phosphorylation of the human T cell antigen receptor ζ-chain: activation via CD3 but not CD2. J. Immunol. 141:3532.
19. Baniyash, M., P. Garcia-Morales, E. Luong, L. E. Samelson, and R. D. Klausner. 1988. The T cell antigen receptor ζ chain is tyrosine phosphorylated upon activation. J. Biol. Chem. 263:18225.
20. Quin, D., I. Griswold-Prenner, M. R. Rosner, and F. W. Fitch. 1993. Multiple components of the T cell antigen receptor complex become tyrosine-phosphorylated upon activation. J. Biol. Chem. 268:4488.
21. June, C. H., M. C. Fletcher, J. A. Ledbetter, and L. E. Samelson. 1990. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144:1591.
22. Secrist, J. P., L. Karnitz, and R. T. Abraham. 1991. T-cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-γ1. J. Biol. Chem. 266:12135.
23. Weiss, A., G. Koretzky, R. C. Schatzman, and T. Kadlecek. 1991. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-γl. Proc. Natl. Acad. Sci. USA 88:5484.
24. Park, D. J., H. W. Rho, and S. G. Rhee. 1991. CD3 stimulation causes phosphorylation of phospholipase C-γ1 on serine and tyrosine residues in a human T-cell line. Proc. Natl. Acad. Sci. USA 88:5453.
25. lck. Nature 338:257.
26. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.
27. lck. Nature 350:62.
28. lck and Ti(TCR):CD3 complexes. Eur. J. Immunol. 21:1663.
29. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.
30. Samelson, L. E., A. F. Phillips, E. T. Luong, and R. D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:4358.
31. fyn(T) activity: detection of associated proteins at 72 and 120-130 KD. Mol. Immunol. 29:1417.
32. Chan, A. C., B. A. Irving, J. D. Fraser, and A. Weiss. 1991. The ζ chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA 88:9166.
33. Chan, A. C., M. Iwashima, C. W. Turck, and A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 71:649.
34. Nishibe, S., M. I. Wahl, S. M. T. Hernandez-Sotomayor, N. K. Tonks, S. G. Rhee, and G. Carpenter. 1990. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation. Science 250:1253.
35. Goldschmidt-Clermont, P. J., J. W. Kim, L. M. Machesky, S. G. Rhee, and T. D. Pollard. 1991. Regulation of phospholipase Cγ1 by profilin and tyrosine phosphorylation. Science 251:1231.
36. Fisher, D. B., and G. C. Mueller. 1968. An early alteration in the phospholipid metabolism of lymphocytes by phytohemagglutinin. Proc. Natl. Acad. Sci. USA 60:1396.
37. Taylor, M. V., J. C. Metcalfe, T. R. Hesketh, G. A. Smith, and J. H. P. Moore. 1984. Mitogens increase phosphorylation of phosphoinositides in thymocytes. Nature 312:462.
38. Imboden, J. B., and J. D. Stobo. 1985. Transmembrane signalling by the T cell antigen receptor:perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:446.
39. ++ mobilization. Biochem. J. 247:695.
40. Ledbetter, J. A., C. H. June, L. S. Grosmaire, and P. S. Rabinovitch. 1987. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. USA 84:1384.
41. Linch, D. C., D. L. Wallace, and K. O'Flynn. 1987. Signal transduction in human T lymphocytes. Immunol. Rev. 95:137.
42. Crabtree, G. R. 1989. Contingent genetic regulatory events in T-lymphocyle activation. Science 243:355.
43. ras during T-cell activation and growth. Immunol. Today 16:159.
44. June, C. H., M. C. Fletcher, J. A. Ledbetter, G. L. Schieven, J. N. Siegel, A. F. Phillips, and L. E. Samelson. 1990. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 87:7722.
45. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1340.
46. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1.
47. + T cells. Science 271:1272.
48. + T cells. Science 271:1276.
49. DeSilva, D. R., W. S. Feeser, E. J. Tancula, and P. A. Scherle. 1996. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signalling pathways. J. Exp. Med. 183:2017.
50. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Invest. 21(Suppl. 97):77.
51. Jundal, M., G. Holm, and H. Wigzell. 1972. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J. Exp. Med. 136:207.
52. Elliott, L. H., S. L. Carlson, L. A. Morford, and J. P. McGillis. 1995. Preparation, characterization, and use of human and rodent lymphocytes, monocytes, and neutrophils. In Methods of Neurosciences, Vol. 24: Neuroimmunology. M. I. Phillips and D. Evans, eds. Academic Press, San Diego, CA, p. 115.
53. Samelson, L. E., M. C. Fletcher, J. A. Ledbetter, and C. H. June. 1990. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway: regulation by the CD45 tyrosine phosphatase. J. Immunol. 145:2448.
54. Kanner, S. B., A. B. Reynolds, and J. T. Parsons. 1989. Immunoaffinity purification of tyrosine-phosphorylated cellular proteins. J. Immunol. Methods 120: 115.
55. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
56. Rabinovitch, P. S., C. H. June, A. Grossmann, and J. A. Ledbetter. 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3: simultaneous use of INDO-1 and immunofluorescence with flow cytometry. J. Immunol. 137:952.
57. Muthusamy, N., A. R. Baluyut, and B. Subbarao B. 1991. Differential regulation of surface Ig-and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. J. Immunol. 147:2483.
58. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3340.
59. 2+ and membrane potential in lymphocytes. Nature 295: 68.
60. Lichtman, A. H., G. B. Degel, and M. A. Lichtman. 1983. The role of calcium in lymphocyte proliferation. Blood 61:413.
61. Rasmussen, H., I. Kujima, K. Kujima, W. Zawalich, and W. Apfeldorf. 1984. Calcium as intracellular messenger:sensitivity modulation, C kinase pathway and sustained cellular response. Adv. Cyclic Nucleotide Protein Phosphorylatian Res. 18:159.
62. Mills, G. B., R. K. Cheung, S. Grinstein, and E. W. Gelfand. 1985. Increase in cytosolic free calcium concentration is an intracellular messenger for the production of interleukin 2 but not for expression of the interleukin 2 receptor. J. Immunol. 134:1640.
63. Greene, W. C., C. M. Parker, and E. W. Parker. 1976. Calcium and lymphocyte activation. Cell. Immunol. 25:74.
64. Roszman, T. L., W. H. Brooks, and L. H. Elliott. 1982. Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273.
65. Nakamura, K., Y. Koga, H. Yoshida, K. Tanaka, M. Sasaki, G. Kimura, and K. Nomoto. 1994. Inhibition of the T-cell receptor-mediated signal transduction by microinjection of anti-Lck monoclonal antibody into T-cells. Biochem. Biophys. Acta 1224:495.
66. Skalhegg, B. S., A. M. Rasmussen, K. Tasken, V. Hansson, T. Jahnsen, and T. Lea. 1994. Cyclic AMP sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex. Scand. J. Immunol. 40:201.
67. Anel, A., G. V. Richieri, and A. M. Kleinfeld. 1994. A tyrosine phosphorylation requirement for cytotoxic T lymphocyte degranulation. J. Biol. Chem. 269:9506.
68. Boussitotis, V. A., D. L. Barber, B. J. Lee, J. G. Gribben, G. J. Freeman, and L. M. Nadler. 1996. Differential association of protein tyrosine kinases with the T-cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J. Exp. Med. 184:365.
69. 2+ response amplitude and duration. Nature 386:885.
70. Healy, J. I., R. E. Dolmetsch, L. A. Timmerman, J. G. Cyster, M. L. Thomas, G. R. Crabtree, R. S. Lewis, and C. C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6:419.
71. Mizoguchi, H., J. J. O'Shea, D. L. Longo, C. M. Loeffler, D. W. McVicar, and A. C. Ochoa. 1992. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258:1795.
72. Nakagomi, H., M. Petersson, I. Magnusson, C. Juhlin, M. Matsuda, H. Mellstedt, J-L. Taupin, E. Vivier, P. Anderson, and R. Kiessling. 1993. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 53: 5610.
73. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53: 5613.
74. Matsuda, M., M. Petersson, R. Lenkei, J-L. Taupin, I. Magnusson, H. Mellstedt, P. Anderson, and R. Kiessling. 1995. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer. 61:765.
75. Tartour, E., S. Latour, C. Mathiot, N. Thiounn, V. Mosseri, J. Joyeux, C. Dubois D'Enghien, R. Lee, B. Debre, and W. Herman Fridman. 1995. Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationships with TIL phenotype and function. Int. J. Cancer 63:205.
76. Wang, Q., J. Stanley, S. Kudoh, J. Myles, V. Kolenko, T. Yi, R. Tubbs, R. Bukowski, and J. Finke. 1995. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J. Immunol. 155:1382.
77. Levey, D. L., and P. K. Srivastava. 1996. Alterations in T cells of cancer-bearers: whence specificity? Immunol. Today 17:365.
78. fyn, ZAP-70, and CD3 ζ despite suppressed cytolytic activity. J. Exp. Med. 182:1029.
79. Franco, J. L., P. Ghosh, R. H. Wiltrout, C. R. D. Carter, A. H. Zea, N. Momozaki, A. C. Ochoa, D. L. Longo, T. J. Sayers, and K. L. Komschlies. 1995. Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res. 55:3840.
80. Brooks, W. H., R. B. Latta, M. S. Mahaley, T. L. Roszman, L. Duka, and C. Skaggs. 1981. Immunobiology of primary intracranial tumors. Part 5. Correlation of a lymphocyte index and clinical status. J. Neurosurg. 54:331.
81. Roszman, T. L., W. H. Brooks, and L. H. Elliott. 1987. Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor. J. Neurosurg. 67:874.
82. Elliott, L. H., W. H. Brooks, and T. L. Roszman. 1992. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. J. Neurooncol. 14:1.
83. Roszman, T. L., W. H. Brooks, and L. H. Elliott. 1991. Modulation of T-cell function by gliomas. Immunol. Today 12:370.
84. Cho, E. A., M. P. Riley, A. L. Siliman, and H. Quill. 1993. Altered protein tyrosine phosphorylation in anergic Th1 cells. J. Immunol. 151:20.
85. + T cells. J. Immunol. 151:2355.
86. Gajewski, T. F., D. Qian, P. Fields, and F. W. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Aci. USA 91:38.
87. Migita, K., K. Eguchi, Y. Kawabe, T. Tsukada, Y. Ichinose, and S. Nagataki. 1995. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 155: 5083.
88. fyn1. J. Immunol. 149:2887.
89. Wrann, M., S. Bodmer, R. de Martin, C. Siepl, R. Hofer-Warbinek, K. Frei, E. Hofer, and A. Fontana. 1987. T-cell suppressor factor form human glioblastoma cells is a 12.5-KDa protein closely related to transforming growth factor-beta. EMBO J. 6:1633.
90. DeMartin, R., B. Haendler, R. Hofer-Warbinek, H. Gaugitsch, M. Wrann, H. Schlusener, J. M. Seifert, S. Bodmer, A. Fontana, and E. Hofer. 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J. 6: 3673.
91. 2. J. Immunol. 143:3222.
92. Nitta, T., M. Hishii, K. Sato, and K. Okumura. 1994. Selective expression of interleukin-10 gene within glioblastoma multiforme. Brain Res. 649:122.
93. Huettner, C., W. Paulus, and W. Roggendorf. 1995. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146:317.
94. Hishii, M., T. Nitta, H. Ishida, M. Ebato, A. Kurosu, H. Yagita, K. Sato, and K. Okumura. 1995. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery 37:1160.